Skip to main content

Want a detailed portfolio tracker?

Curis (CRIS) P/E (2011 - 2026)

Curis (CRIS) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Curis (CRIS) P/E is -0.46. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Curis (CRIS)

YearP/EChange
2026-0.46-56.87%
2025-1.06+137.48%
2024-0.45-67.59%
2023-1.38+59.95%
2022-0.86-90.99%
2021-9.60-86.28%
2020-69.94+696.62%
2019-8.78+150.26%
2018-3.51-61.71%
2017-9.16-72.21%
2016-32.97+3.99%
2015-31.70-7.94%
2014-34.44-63.66%
2013-94.75+13.25%
2012-83.66-25.30%
2011-111.99N/A

Comparison Curis (CRIS) P/E with competitors

Curis (CRIS) P/E is -0.46.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.37%
NBYStablecoin Development Corp0.00-100.94%
ENLVEnlivex Ltd0.07-116.29%
FGENFibroGen Inc0.24-152.26%
CHRSCoherus Biosciences Inc0.85-284.75%
FBIOFortress Biotech Inc0.95-306.63%
ORMPOramed Pharmaceuticals Inc1.50-427.25%
AGENAgenus Inc3.01-755.27%
INVAInnoviva Inc3.15-786.71%
VXRTVaxart Inc3.55-872.86%
CVACCureVac N.V.4.45-1067.93%
GLPGGalapagos NV4.86-1157.90%
SRPTSarepta Therapeutics Inc4.88-1162.95%
ABEOAbeona Therapeutics Inc5.39-1272.99%
ABUSArbutus Biopharma Corp5.60-1318.30%
ZVRAZevra Therapeutics Inc5.89-1381.79%
SPROSpero Therapeutics Inc6.23-1456.08%
CGENCompugen Ltd6.31-1474.70%
RIGLRigel Pharmaceuticals6.87-1596.21%
SLXNSilexion Therapeutics Corp7.30-1688.53%
OMEROmeros Corporation9.26-2115.85%
AUPHAurinia Pharmaceuticals Inc9.58-2186.88%
PLXProtalix BioTherapeutics Inc10.89-2471.24%
ACADAcadia Pharmaceuticals Inc11.73-2653.59%
TBPHTheravance Biopharma Inc12.26-2769.77%
ADMAAdma Biologics Inc12.42-2803.73%
HRMYHarmony Biosciences Holdings Inc13.82-3109.00%
SABSSAB Biotherapeutics Inc14.14-3177.80%
NAGENiagen Bioscience Inc14.82-3326.27%
INCYIncyte Corp15.82-3544.96%
REGNRegeneron Pharmaceuticals Inc15.86-3552.39%
PBYIPuma Biotechnology Inc17.32-3870.06%
CPRXCatalyst Pharmaceuticals Inc17.44-3896.97%
EXELExelixis Inc17.54-3918.46%
TGTXTG Therapeutics Inc18.97-4229.38%
MDXGMimedx Group Inc20.55-4574.79%
XOMAXOMA Royalty Corp22.87-5080.52%
ARGXArgen X SE24.30-5390.42%
CTMXCytomX Therapeutics Inc24.82-5504.31%
XOMAOXOMA Royalty Corp25.34-5618.34%
HALOHalozyme Therapeutics Inc25.62-5679.06%
XOMAPXOMA Royalty Corp25.67-5689.17%
VRTXVertex Pharmaceuticals Inc27.99-6195.31%
RPRXRoyalty Pharma plc - Class A28.69-6346.15%
SLNOSoleno Therapeutics Inc29.02-6417.53%
ASNDAscendis Pharma A/S30.09-6650.54%
LGNDLigand Pharmaceuticals Inc - Class B37.91-8354.60%
APLSApellis Pharmaceuticals Inc39.02-8596.11%
BMRNBiomarin Pharmaceutical Inc42.21-9290.81%
KRYSKrystal Biotech Inc45.34-9972.66%
ONCBeiGene Ltd69.54-15241.08%
PHARPharming Group N.V.75.03-16435.37%
TECHBio-Techne Corp101.96-22299.47%
VCELVericel Corp109.92-24033.25%
ALNYAlnylam Pharmaceuticals Inc117.96-25784.62%
GMABGenmab140.29-30645.60%
TLXTelix Pharmaceuticals Ltd162.15-35405.65%
CORTCorcept Therapeutics Inc212.86-46445.61%